GO:1904902 ESCRT III complex assembly: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1904902 describes the aggregation, arrangement and bonding together of components to form an ESCRT III complex.
ESCRT III assembly is driven by electrostatic lateral interactions between CHMP proteins, enabling heteropolymer formation and membrane remodeling.
The core reaction involves sequential recruitment and polymerization of CHMP2A, CHMP3, CHMP4, and other ESCRT III subunits at membranes.
ESCRT III assembly is essential for membrane scission events, including multivesicular endosome formation, lysosome repair, and autophagic cell death.
Dysregulation of ESCRT III assembly is linked to cancer progression, neurodegenerative conditions, and viral budding.
CRISPR knockout, point mutation, knock-in, and overexpression models are key tools to dissect ESCRT III assembly mechanisms and disease relevance.

Description

ESCRT III complex assembly (GO:1904902) is the biological process by which a set of protein components aggregates, arranges, and bonds together to form an ESCRT III complex. This process is a central step in the endosomal sorting complex required for transport (ESCRT) pathway, which mediates membrane deformation and scission events across diverse cellular contexts. The ESCRT III complex is composed of charged multivesicular body proteins (CHMPs) that assemble into helical polymers on membranes to drive fission. Understanding how these components assemble is critical for researchers studying membrane trafficking, autophagy, viral budding, and lysosomal repair. The assembly of ESCRT III is not a simple linear pathway but a highly regulated, dynamic process involving electrostatic interactions, conformational changes, and disassembly factors. Recent structural and biochemical studies have revealed that CHMP2A and CHMP3 co-assemble into copolymers that constrict membranes, while CHMP4 proteins form the initial filaments that template further assembly. This process is hijacked by viruses such as SARS-CoV-2 to facilitate virus-like particle formation, and it is also co-opted during autophagic cell death in breast cancer. For researchers, GO:1904902 provides a precise ontological handle to annotate genes and proteins involved in ESCRT III assembly, enabling functional enrichment, pathway analysis, and disease modeling. The term is particularly relevant for studies on multivesicular endosome biogenesis, lysosome membrane repair, and the interface between autophagy and cell death. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of ESCRT III complex assembly, its key genes, regulatory mechanisms, disease links, and experimental approaches.

ESCRT III complex assembly At A Glance

GO ID GO:1904902
GO term ESCRT III complex assembly
Ontology biological_process
Synonym ESCRT III complex formation
Major function Assembly of ESCRT III complex for membrane scission and remodeling
Cellular context Endosomal membranes, plasma membrane, lysosomes, autophagosomes
Key proteins CHMP2A, CHMP3, CHMP4A/B/C, CHMP1A/B, CHMP5, CHMP6, CHMP7, VPS4, IST1
Regulatory factors Electrostatic interactions, ATPase VPS4, Lgd, YAP1, NEDD4L
Disease relevance Cancer, viral infection, neurodegeneration, lysosomal storage disorders

What Is GO:1904902?

GO:1904902, ESCRT III complex assembly, is defined as the aggregation, arrangement and bonding together of a set of components to form an ESCRT III complex. In other words, it is the process by which individual ESCRT III protein subunits come together in a spatially and temporally controlled manner to build a functional ESCRT III complex, which can then perform membrane remodeling and scission functions.

Why Is ESCRT III complex assembly Important in Cell Biology?

ESCRT III complex assembly is a fundamental cellular process that governs membrane scission events essential for endosomal sorting, autophagy, lysosome repair, and viral budding. Disruption of this assembly leads to defective multivesicular body formation, impaired autophagic flux, and accumulation of damaged lysosomes, which are hallmarks of cancer and neurodegenerative diseases. Moreover, pathogens such as SARS-CoV-2 exploit ESCRT III assembly to produce virus-like particles, making this process a potential antiviral target. Understanding the molecular details of ESCRT III assembly is therefore critical for both basic cell biology and translational research.
Required for intralumenal vesicle formation at multivesicular endosomes, controlling receptor downregulation.
Essential for lysosome membrane repair after damage, preventing cell death.
Mediates autophagic cell death in breast cancer via cytoplasmic YAP1-mediated assembly.
Facilitated by electrostatic lateral interactions among CHMP proteins, enabling heteropolymer assembly.
Hijacked by SARS-CoV-2 spike protein to induce virus-like particles and improve mRNA vaccines.
Regulated by Lgd at multivesicular endosomes to control ESCRT-III accumulation.
Structural basis of CHMP2A-CHMP3 copolymer assembly provides targets for therapeutic intervention.
Disassembly by VPS4 ATPase is coupled to assembly cycles, ensuring dynamic membrane remodeling.
Mutations in ESCRT III components are linked to neurodegenerative diseases and cancer.
CRISPR screening of ESCRT III genes can identify novel regulators of membrane scission.

What Happens During ESCRT III complex assembly?

Initiation and Recruitment of ESCRT III Subunits
In simple terms: The first step is getting the right proteins to the right place on the membrane.
ESCRT III assembly begins with the recruitment of CHMP proteins to specific membrane domains, often marked by upstream ESCRT components or specific lipid compositions. CHMP4 proteins, including CHMP4A, CHMP4B, and CHMP4C, are among the first to arrive and form the initial filamentous template. This recruitment is tightly regulated by interactions with ESCRT II and other adaptors, ensuring assembly occurs at the correct time and location. Electrostatic interactions between the positively charged N-terminal region of CHMP proteins and negatively charged membrane lipids facilitate membrane binding and subsequent polymerization.
Polymerization and Heteropolymer Formation
In simple terms: The proteins link together like beads on a string to form a flexible polymer.
Once recruited, CHMP proteins polymerize into helical filaments through electrostatic lateral interactions. CHMP2A and CHMP3 co-assemble into copolymers that are critical for membrane constriction and cleavage. Structural studies have revealed that CHMP2A-CHMP3 polymers adopt a curved architecture that can deform membranes. The heteropolymer composition is dynamic, with different CHMP subunits contributing distinct biophysical properties. This polymerization step is reversible and coupled to ATP hydrolysis by VPS4, which disassembles the complex after membrane scission.
Membrane Deformation and Scission
In simple terms: The assembled polymer squeezes the membrane until it pinches off.
The assembled ESCRT III complex constricts the membrane, leading to scission and release of vesicles or repair of membrane wounds. This process is essential for intralumenal vesicle formation at multivesicular endosomes, where ESCRT III accumulation is regulated by Lgd. In lysosome repair, ESCRT III assembly is coupled to damage sensing via LASER, which recruits the machinery to injured membranes. The mechanical force for scission is generated by the polymerization and conformational changes of CHMP proteins, particularly CHMP2A-CHMP3 copolymers.
Disassembly and Recycling
In simple terms: After the job is done, the complex is taken apart so the pieces can be reused.
Following membrane scission, the ESCRT III complex is disassembled by the AAA-ATPase VPS4, which extracts CHMP subunits from the membrane. This disassembly step is crucial for recycling ESCRT III components and maintaining cellular pools for subsequent rounds of assembly. The interplay between assembly and disassembly ensures that ESCRT III activity is spatially and temporally controlled. Dysregulation of disassembly can lead to accumulation of ESCRT III polymers and impaired membrane trafficking.
Regulation by Post-translational Modifications and Interacting Proteins
In simple terms: Other proteins can add chemical tags to control when and where assembly happens.
ESCRT III assembly is regulated by post-translational modifications and interacting proteins. For example, cytoplasmic YAP1 promotes ESCRT-III assembly during autophagic cell death, and this process is ubiquitinated by NEDD4L in breast cancer. Lgd regulates ESCRT-III complex accumulation at multivesicular endosomes to control intralumenal vesicle formation. These regulatory mechanisms ensure that ESCRT III assembly is responsive to cellular stress, damage, and signaling cues.

Key Genes Involved in GO:1904902 ESCRT III complex assembly

The following genes and proteins are central to ESCRT III complex assembly, based on verified literature and QuickGO annotations.
GeneMajor RoleResearch Relevance
CHMP2ACore subunit forming copolymers with CHMP3 for membrane scissionStructural studies, KO models for membrane remodeling
CHMP3Co-assembles with CHMP2A to form constricting polymersPoint mutations to dissect polymerization interface
CHMP4AInitiates filament formation and recruits other CHMPsOverexpression and KO to study assembly initiation
CHMP4BMajor ESCRT III subunit for membrane buddingKnockout models for endosomal sorting defects
CHMP4CRegulates abscission and membrane scissionKnock-in of tagged versions for imaging
CHMP1AAccessory subunit involved in ESCRT III assemblyKO to study MVB sorting
CHMP1BAccessory subunit with roles in membrane repairKnockout for lysosome repair assays
CHMP5Stabilizes ESCRT III polymersOverexpression to enhance assembly
CHMP6Links ESCRT II to ESCRT IIIKO to block assembly initiation
CHMP7Nuclear envelope reformation and ESCRT III assemblyPoint mutations for nuclear envelope studies
VPS4AATPase that disassembles ESCRT IIIKO leads to accumulated ESCRT III polymers
VPS4BParalog of VPS4A, disassembly factorDouble KO for synthetic lethality studies
IST1Regulates ESCRT III disassembly and recyclingKnock-in for live-cell imaging
LgdRegulates ESCRT-III accumulation at endosomesKO models for MVB formation defects
YAP1Promotes ESCRT-III assembly in autophagic cell deathOverexpression and KO in breast cancer models
NEDD4LUbiquitinates YAP1 to regulate ESCRT-III assemblyPoint mutations to map ubiquitination sites
LASERCouples damage sensing to ESCRT assembly for lysosome repairKO models for lysosome repair deficiency

How Is ESCRT III complex assembly Regulated?

ESCRT III complex assembly is regulated at multiple levels. Electrostatic lateral interactions between CHMP proteins drive heteropolymer assembly and are sensitive to membrane lipid composition. The ATPase VPS4 controls disassembly, and its activity is coupled to assembly cycles. Post-translational modifications, such as ubiquitination of YAP1 by NEDD4L, regulate ESCRT-III assembly during autophagic cell death. Lgd regulates ESCRT-III accumulation at multivesicular endosomes, ensuring proper intralumenal vesicle formation. Additionally, damage sensing via LASER couples lysosome injury to ESCRT assembly for membrane repair. These regulatory mechanisms ensure that ESCRT III assembly is responsive to cellular needs and stress signals.

ESCRT III complex assembly and Human Disease

GeneDisease / BiologyPotential Experimental Model
YAP1Breast cancer, autophagic cell deathKnockout and overexpression in breast cancer cell lines
NEDD4LBreast cancer, regulation of YAP1 ubiquitinationPoint mutations to disrupt ubiquitination
CHMP2ANeurodegeneration, membrane trafficking defectsKnock-in of patient mutations in iPSC-derived neurons
CHMP3Lysosomal storage disordersKnockout in HeLa cells for lysosome repair assays
LASERLysosome repair deficiencyKnockout in mammalian cells for damage sensing
ESCRT III Assembly in Cancer
Dysregulation of ESCRT III assembly is implicated in cancer. In breast cancer, cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death, and this process is ubiquitinated by NEDD4L. This suggests that modulating ESCRT III assembly could influence cancer cell survival and death pathways. Additionally, ESCRT III components are involved in receptor downregulation and signaling, which are frequently altered in cancer.
ESCRT III Assembly and Viral Infection
Viruses exploit ESCRT III assembly for budding and release. SARS-CoV-2 spike protein recruits ESCRT machinery to induce virus-like particles, which can be harnessed to improve mRNA vaccines. This highlights the importance of ESCRT III assembly in viral pathogenesis and vaccine development.
ESCRT III Assembly in Lysosomal and Neurodegenerative Disorders
ESCRT III assembly is critical for lysosome membrane repair, and its failure leads to lysosomal damage and cell death. Neurodegenerative diseases often involve lysosomal dysfunction, and ESCRT III mutations have been linked to conditions such as hereditary spastic paraplegia and amyotrophic lateral sclerosis. Understanding ESCRT III assembly in neurons may reveal therapeutic targets for neurodegeneration.
ESCRT III Assembly in Liver Disease
The interplay between autophagy, lipid droplets, and liver disease involves ESCRT III assembly, as autophagic processes depend on ESCRT-mediated membrane remodeling. Dysfunctional ESCRT III assembly may contribute to hepatic steatosis and liver injury.

From ESCRT III complex assembly-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the role of CHMP2A in ESCRT III assembly?CRISPR knockout of CHMP2A in HeLa cells
How does YAP1 promote ESCRT-III assembly in cancer?Overexpression and knockout of YAP1 in breast cancer cells
What are the structural requirements for CHMP2A-CHMP3 copolymerization?Point mutations in CHMP2A and CHMP3 followed by structural analysis
How does Lgd regulate ESCRT-III accumulation?Knockout of Lgd in Drosophila or mammalian cells
Can ESCRT III assembly be visualized in live cells?Knock-in of fluorescent tags on CHMP4B
What is the role of NEDD4L in ESCRT III assembly?Point mutation of ubiquitination sites in YAP1

How to Study the ESCRT III complex assembly Process

MethodWhat It MeasuresTypical Application
Live-cell fluorescence microscopyDynamics of ESCRT III assembly and disassemblyTracking CHMP4B recruitment to membranes
Cryo-EMHigh-resolution structure of ESCRT III polymersCHMP2A-CHMP3 copolymer architecture
In vitro reconstitutionPolymerization and membrane scission activityElectrostatic interactions among CHMPs
CRISPR knockout screeningIdentification of genes regulating ESCRT III assemblyCancer cell survival and autophagic cell death
ImmunoprecipitationProtein-protein interactions within ESCRT IIICHMP2A-CHMP3 complex formation
RNA-seqTranscriptional changes upon ESCRT III perturbationKnockout models to assess pathway feedback
ProteomicsPost-translational modifications and interactomeUbiquitination of YAP1 by NEDD4L
Lysosome repair assayRecruitment of ESCRT III to damaged lysosomesLASER-mediated damage sensing
Fluorescence Microscopy and Live-Cell Imaging
Fluorescence microscopy, including live-cell imaging, is used to visualize ESCRT III assembly dynamics. Tagged CHMP proteins (e.g., GFP-CHMP4B) allow tracking of polymerization and disassembly at membranes. Super-resolution microscopy can resolve the helical architecture of ESCRT III polymers.
Structural Biology (Cryo-EM and X-ray Crystallography)
Cryo-electron microscopy and X-ray crystallography have provided high-resolution structures of CHMP2A-CHMP3 copolymers, revealing the molecular basis of membrane constriction. These methods are essential for understanding how point mutations affect assembly.
Biochemical Assays for Polymerization
In vitro reconstitution assays with purified CHMP proteins and liposomes measure polymerization, membrane binding, and scission activity. These assays can be combined with mutagenesis to dissect electrostatic interactions.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify novel regulators of ESCRT III assembly and membrane trafficking. Such screens have revealed roles for YAP1 and NEDD4L in autophagic cell death.

How CRISPR Can Be Used to Study GO:1904902 ESCRT III complex assembly

Knockout

CRISPR knockout of ESCRT III genes such as CHMP2A, CHMP3, or CHMP4B abolishes assembly and leads to defects in membrane scission, multivesicular body formation, and lysosome repair. Knockout models are used to study the loss-of-function phenotypes and to validate gene essentiality.

Point Mutation

Point mutations can be introduced into ESCRT III genes to dissect specific residues required for electrostatic interactions, polymerization, or regulation. For example, mutating charged residues in CHMP2A disrupts copolymer assembly with CHMP3.

Knock-in

Knock-in of fluorescent tags (e.g., GFP, mCherry) into endogenous ESCRT III loci allows real-time visualization of assembly dynamics at physiological expression levels. Knock-in of disease-associated mutations can model human disorders.

Overexpression

Overexpression of ESCRT III components, such as YAP1 or CHMP4B, can enhance assembly and drive autophagic cell death or membrane remodeling. Overexpression models are useful for gain-of-function studies and for identifying downstream effects.

How EDITGENE Supports ESCRT III complex assembly Research

Researchers studying ESCRT III complex assembly-related genes often need to determine whether a candidate gene is causally involved in membrane scission, lysosome repair, or cancer cell death. EDITGENE provides comprehensive CRISPR services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling precise functional dissection of ESCRT III assembly pathways.
Contact EDITGENE today to design your custom CRISPR model for ESCRT III complex assembly research.

Frequently Asked Questions About ESCRT III complex assembly

ESCRT III complex assembly (GO:1904902) is the process by which ESCRT III protein subunits aggregate, arrange, and bond together to form a functional ESCRT III complex, which mediates membrane scission and remodeling.
Key genes include CHMP2A, CHMP3, CHMP4A/B/C, CHMP1A/B, CHMP5, CHMP6, CHMP7, VPS4A/B, IST1, and regulators such as YAP1, NEDD4L, and Lgd.
It drives membrane scission events essential for multivesicular endosome formation, lysosome repair, autophagic cell death, and viral budding.
It is regulated by electrostatic interactions among CHMP proteins, ATP-dependent disassembly by VPS4, post-translational modifications such as ubiquitination, and proteins like Lgd and LASER.
Dysregulation is linked to breast cancer, neurodegenerative disorders, lysosomal storage diseases, and viral infections such as SARS-CoV-2.
CHMP2A co-assembles with CHMP3 to form copolymers that constrict membranes and drive scission.
Cytoplasmic YAP1 promotes ESCRT-III assembly during autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as in vitro reconstitution and structural biology approaches.
VPS4 is an ATPase that disassembles ESCRT III complexes after membrane scission, recycling components for further rounds of assembly.
SARS-CoV-2 spike protein recruits ESCRT machinery to induce virus-like particles, which can be used to improve mRNA vaccines.

Conclusion

ESCRT III complex assembly (GO:1904902) is a dynamic and essential process for membrane scission, with critical roles in endosomal sorting, lysosome repair, autophagy, and viral budding. Its dysregulation contributes to cancer, neurodegeneration, and infectious diseases, making it a compelling target for basic and translational research. Advances in CRISPR modeling, structural biology, and live-cell imaging continue to unravel the molecular details of ESCRT III assembly, offering new opportunities for therapeutic intervention.

References

  1. 1. Guo Y et al.. 2023. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.. Cancer Commun (Lond) 43(5):582-612 PMID: 37005481
  2. 2. Filali-Mouncef Y et al.. 2022. The ménage à trois of autophagy, lipid droplets and liver disease.. Autophagy 18(1):50-72 PMID: 33794741
  3. 3. Adell MA et al.. 2011. Assembly and disassembly of the ESCRT-III membrane scission complex.. FEBS Lett 585(20):3191-6 PMID: 21924267
  4. 4. Hoffmann MAG et al.. 2023. ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines.. Cell 186(11):2380-2391.e9 PMID: 37146611
  5. 5. Banjade S et al.. 2019. Electrostatic lateral interactions drive ESCRT-III heteropolymer assembly.. Elife 8 PMID: 31246173
  6. 6. Goul CS et al.. 2026. LASER couples damage sensing to ESCRT assembly for lysosome repair.. Nature 656(8126):216-226 PMID: 42236937
  7. 7. Azad K et al.. 2023. Structural basis of CHMP2A-CHMP3 ESCRT-III polymer assembly and membrane cleavage.. Nat Struct Mol Biol 30(1):81-90 PMID: 36604498
  8. 8. Clarke AL et al.. 2022. Lgd regulates ESCRT-III complex accumulation at multivesicular endosomes to control intralumenal vesicle formation.. Mol Biol Cell 33(14):ar144 PMID: 36287829
Contact Us
*
*
*
*
How did you hear about us: